Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03938974 · ClinicalTrials.gov registry record

Social Self-Management of Parkinson's Disease

A clinical trial of Parkinson Disease, sponsored by Tufts University.

Completed
Registry status
146
Enrollment target
2
Study locations

NCT03938974 is a study of Parkinson Disease that has completed, run by Tufts University. The registered enrollment target is 146 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03938974, a study of Parkinson Disease, has completed, sponsored by Tufts University.

COMPLETED
Registry status
146 participants
Enrollment target
2
Study locations

Study Summary

Parkinson's disease (PD) affects 1% to 2% of the US population over age 60, and its prevalence is increasing as the population ages. The proposed research will establish the natural evolution of the social lives of people with Parkinson's disease and their families and its relationship to health outcomes, and thus has the potential to significantly advance Parkinson's disease research and evidence-based neurological nursing and rehabilitation. The project develops the new construct of social self-management of chronic disease and results will inform the development of new interventions aimed at supporting social integration and preventing isolation and loneliness in people living with Parkinson's disease.

Conditions Studied

Study Locations (2)

Massachusetts

  • Boston Medical Center - Boston
  • Tufts University - Medford

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2013-09-23
Est. Completion 2019-03-31

Sponsor

Tufts University

163 total trials

What the Registry Record Tells You About NCT03938974

The ClinicalTrials.gov registry entry for NCT03938974 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (97% lower). The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.

NCT03938974 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03938974 about?

NCT03938974 is a clinical study titled "Social Self-Management of Parkinson's Disease". Parkinson's disease (PD) affects 1% to 2% of the US population over age 60, and its prevalence is increasing as the population ages. The proposed research will establish the natural evolution of the social lives of people with Parkinson's disease and their families and its relationship to health out...

What is the current status of trial NCT03938974?

This trial is currently completed. The enrollment target is 146 participants. The study started on 2013-09-23. Estimated completion is 2019-03-31.

What conditions does trial NCT03938974 study?

This clinical trial studies the following conditions: Parkinson Disease.

Who is sponsoring clinical trial NCT03938974?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03938974 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.